Cargando…
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
Immunotherapies have been accelerating the development of anti-cancer clinical treatment, but its low objective responses and severe off-target immune-related adverse events (irAEs) limit the range of application. Strategies to remove these obstacles primarily focus on the combination of different t...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779686/ https://www.ncbi.nlm.nih.gov/pubmed/33408716 http://dx.doi.org/10.3389/fimmu.2020.601497 |